Microba Life Sciences lists on ASX
Gut health business Microba Life Sciences Ltd (ASX: MAP) has successfully listed on the Australian Securities Exchange, in an initial public offering that raised $30 million. Firm: Thomson Geer (Micro
Source: lawyersweekly.com.au